.

BioPharmaceutical Business Intelligence

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Cantor Fitzgerald
Farmers Insurance
Daiichi Sankyo
UBS
Teva
Johnson and Johnson
Accenture
Harvard Business School
Chinese Patent Office

Generated: December 16, 2017

DrugPatentWatch Database Preview

Solvay Company Profile

« Back to Dashboard

What is the competitive landscape for SOLVAY, and what generic and branded alternatives to SOLVAY drugs are available?

SOLVAY has sixty-three approved drugs.



Summary for Solvay

US Patents:0
Tradenames:45
Ingredients:34
NDAs:63
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
SolvayRETETtetracycline hydrochlorideCAPSULE;ORAL061443-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
SolvayRETETtetracycline hydrochlorideCAPSULE;ORAL061443-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
SolvayPROVAL #3acetaminophen; codeine phosphateCAPSULE;ORAL085685-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
SolvayMETHOCARBAMOLmethocarbamolTABLET;ORAL084449-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
SolvayLITHONATElithium carbonateCAPSULE;ORAL016782-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
SolvayDEXONE 4dexamethasoneTABLET;ORAL084992-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
SolvaySPRX-3phendimetrazine tartrateCAPSULE;ORAL085897-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
SolvayHYDRALAZINE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDEhydralazine hydrochloride; hydrochlorothiazideCAPSULE;ORAL087609-001Feb 8, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
SolvayRESERPINE, HYDRALAZINE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDEhydralazine hydrochloride; hydrochlorothiazide; reserpineTABLET;ORAL088376-001Oct 28, 1983DISCNNoNo► Subscribe► Subscribe► Subscribe
SolvayBUTABARBITAL SODIUMbutabarbital sodiumTABLET;ORAL083606-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Solvay

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
SolvayLUVOXfluvoxamine maleateTABLET;ORAL020243-001Dec 5, 1994► Subscribe► Subscribe
SolvayLUVOXfluvoxamine maleateTABLET;ORAL020243-004Dec 5, 1994► Subscribe► Subscribe
SolvayLUVOXfluvoxamine maleateTABLET;ORAL020243-003Dec 5, 1994► Subscribe► Subscribe
SolvayLUVOXfluvoxamine maleateTABLET;ORAL020243-002Dec 5, 1994► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Novartis
US Army
Harvard Business School
Healthtrust
Mallinckrodt
Dow
Baxter
Teva
Chubb
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot